TrialActa diabetologica2020

Abrogation of postprandial triglyceridemia with dual PPAR α/γ agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Ashu Rastogi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.